Covestor LTD Medpace Holdings, Inc. Transaction History

Covestor LTD

$160 Million
Q3 2024

A detailed history of Covestor LTD transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Covestor LTD holds 599 shares of MEDP stock, worth $211,698. This represents 0.13% of its overall portfolio holdings.

Number of Shares

599

Previous 634 5.52%

Holding current value

$211,698

Previous $261,000 22.99%

% of portfolio

0.13%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$320.58 - $457.29 $11,220 - $16,005	-35 Reduced 5.52%	599 $201,000
Q2 2024 Aug 09, 2024	BUY	$372.0 - $424.34 $3,348 - $3,819	9 Added 1.44%	634 $261,000
Q1 2024 May 10, 2024	SELL	$284.87 - $413.31 $80,333 - $116,553	-282 Reduced 31.09%	625 $253,000
Q4 2023 Feb 09, 2024	BUY	$227.52 - $312.68 $3,867 - $5,315	17 Added 1.91%	907 $278,000
Q3 2023 Nov 13, 2023	SELL	$233.98 - $281.67 $41,882 - $50,418	-179 Reduced 16.74%	890 $216,000
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $157,860 - $202,463	843 Added 373.01%	1,069 $257,000
Q1 2023 May 15, 2023	SELL	$174.31 - $239.52 $118,356 - $162,634	-679 Reduced 75.03%	226 $43,000
Q4 2022 Feb 13, 2023	BUY	$153.06 - $226.57 $3,826 - $5,664	25 Added 2.84%	905 $192,000
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $62,260 - $78,288	429 Added 95.12%	880 $138,000
Q2 2022 Aug 10, 2022	SELL	$130.2 - $168.03 $1,302 - $1,680	-10 Reduced 2.17%	451 $68,000
Q1 2022 May 13, 2022	SELL	$138.87 - $214.31 $13,470 - $20,788	-97 Reduced 17.38%	461 $75,000
Q4 2021 Feb 10, 2022	BUY	$182.74 - $227.9 $101,968 - $127,168	558 New	558 $122,000

Others Institutions Holding MEDP

# of Institutions

628

Shares Held

25.1M

Call Options Held

38.7K

Put Options Held

64.7K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $11B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account